Metformin plus megestrol acetate compared with MA alone as fertility‐sparing treatment in patients with atypical endometrial hyperplasia and well‐differentiated endometrial cancer: a randomised controlled trial

Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer

(2019) Bingyi Yang et al.   GYNECOLOGIC ONCOLOGY

Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism

(2019) Jiyoung Lee et al.   NATURE

Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients

(2018) Bingyi Yang et al.   Journal of Gynecologic Oncology

Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer

(2018) Simon R. Lord et al.   Cell Metabolism

Metformin as a Therapeutic Target in Endometrial Cancers

(2018) Teresa Y. Lee et al.   Frontiers in Oncology

Effects of metformin on endometrial cancer: Systematic review and meta-analysis

(2017) Cinthia G. Meireles et al.   GYNECOLOGIC ONCOLOGY

Associations between anthropometric parameters and lipid profiles in Chinese individuals with age ≥40 years and BMI

(2017) Zhi Yang et al.   PLoS One

Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells

(2017) Jingbo Zhang et al.   Oncology Letters

Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers

(2016) Xiaojing Liu et al.   Cell Metabolism

Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform

(2016) Silke Gillessen et al.   EUROPEAN UROLOGY

Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial

(2016) Takuma Higurashi et al.   LANCET ONCOLOGY

Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer

(2015) A. Mitsuhashi et al.   ANNALS OF ONCOLOGY

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional study

(2014) Weiwei Shan et al.   GYNECOLOGIC ONCOLOGY

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia

(2014) Weiwei Shan et al.   Journal of Gynecologic Oncology

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   BLOOD PRESSURE

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

(2012) Ioannis D. Gallos et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression

(2011) Zhenbo Zhang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study

(2010) Wilfried Dinh et al.   Cardiovascular Diabetology

Conservative treatment of early endometrial cancer: Preliminary results of a pilot study

(2010) Giuseppe Laurelli et al.   GYNECOLOGIC ONCOLOGY

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

(2010) Ya Xie et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY